Back to Search
Start Over
Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar.
- Source :
-
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Jul; Vol. 30 (5), pp. 792-801. Date of Electronic Publication: 2023 Jul 11. - Publication Year :
- 2024
-
Abstract
- Introduction: Drug-related problems (DRPs) affect the health outcomes of patients during hospitalization. We sought to analyze the clinical pharmacist-documented interventions among hospitalized patients in the cancer hospital in Qatar.<br />Methods: A retrospective analysis of electronically reported clinical pharmacist interventions of patients admitted to cancer units at Hamad Medical Corporation, Qatar was conducted. Extracted data was based on an overall 3-month follow-up period; March 1-31, 2018, July 15-August 15, 2018 and January 1-31, 2019. Categorical variables were expressed as frequencies and percentages, while continuous variables were expressed as mean ± standard deviation (SD).<br />Results: A total of 281 cancer patients with 1354 interventions were included. The average age of the study participants was 47 years (SD ± 17.36). The majority of the study population was females ( n = 154, 54.80%). The prevailing pharmacist intervention was the addition of a drug therapy ( n = 305, 22.53%), followed by medication discontinuation ( n = 288, 21.27%) and the addition of a prophylactic agent ( n = 174, 12.85%). This pattern was similar across all subgroups (i.e., gender, age, ward), except for the urgent care unit, where an increase in medication dose was the third highest frequently identified intervention ( n = 3, 0.22%). The two medication groups associated with the majority of interventions were the anti-infective and fluid/electrolyte agents. Most of the interventions documented were in the oncology ward (73.19%), while the urgent care unit had the least documented interventions (1.62%).<br />Conclusions: Our analysis showed that clinical pharmacists can effectively identify and prevent DRPs among hospitalized cancer patients.<br />Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
- Subjects :
- Humans
Qatar epidemiology
Female
Male
Middle Aged
Retrospective Studies
Adult
Aged
Hospitalization statistics & numerical data
Professional Role
Drug-Related Side Effects and Adverse Reactions epidemiology
Drug-Related Side Effects and Adverse Reactions prevention & control
Antineoplastic Agents therapeutic use
Cancer Care Facilities
Pharmacy Service, Hospital
Pharmacists
Neoplasms drug therapy
Neoplasms epidemiology
Subjects
Details
- Language :
- English
- ISSN :
- 1477-092X
- Volume :
- 30
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
- Publication Type :
- Academic Journal
- Accession number :
- 37431260
- Full Text :
- https://doi.org/10.1177/10781552231187305